Measure Lung Health From Hospital to Home

The world’s only FDA-cleared biosensor that is clinically validated to detect both coughing, wheezing, ronchi and other adventitious breathing sounds over time without requiring episodic patient intervention.

As demonstrated in 4 ATS publications, RESP can be used continuously and has a much greater sensitivity than intermittent monitoring using an electronic stethoscope. These studies have demonstrated the greater sensitivity of the Strados RESP compared to the Littman electronic stethoscope.

RESP™ offers clinicians a cost-effective, non-invasive and wireless solution that enables early, remote detection of key changes in lung acoustics and ventilation patterns of patients.

It’s a small, unobtrusive, and hands-free biosensor—that many patients forget they are even wearing. The RESP biosensor records and stores every lung sound, whether a patient is sleeping, working out or enjoying time with family.

We designed the RESP biosensor to be non-invasive and comfortable while being easy to use, as it has no wires and is hands-free. This translates into longer wear times and an astounding 99.59% patient compliance. It also means better data for your care team, your physician and a faster time to diagnosis.

Our clinically validated bioacoustic library of sounds and RESP AI engine is the world’s largest entirely hands-free, clinical-grade dataset enabling Strados Labs to be the standard-bearer of acoustic digital biomarkers for clinical research and respiratory care globally.

Current alternatives can only count coughs, while our proprietary technology acquires stethoscope-quality sounds like wheezing, cough spasms, ronchi, and other adventitious lung sound events (including chest wall movements) without requiring episodic patient intervention.

This is a reliable method to objectively detect and effectively communicate the signs and symptoms of these patients with their care teams, in real time and at low cost.

It also provides continuous recording and identification of respiratory signs and symptoms of interest–allowing a better understanding of the progression of the patient’s respiratory status without auscultation by a clinician.